Clinical Trials Browser

Phase 2 × Esophageal Squamous Cell Carcinoma × spartalizumab × Clear all

NCT06122493 2023-11-08

Optimization of Treatment Strategy for Unresectable cN3 Esophageal Squamous Cell Carcinoma

Phase 2 Recruiting

Gastrointestinal

Esophageal Squamous Cell Carcinoma